Profiles

Keywords
Last Name
Institution

Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.

Haynes KR, Tseng HW, Kneissel M, Glant TT, Brown MA, Thomas GP. Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression. BMC Musculoskelet Disord. 2015 Nov 26; 16:368.

View in: PubMed

collapse authors with profiles